Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note released on Thursday morning. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.70 on Thursday. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.22. The stock has a market capitalization of $21.00 million, a P/E ratio of -1.30 and a beta of 2.08. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The company’s fifty day moving average is $0.78 and its two-hundred day moving average is $0.74.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC lifted its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 361,253 shares of the company’s stock after buying an additional 31,140 shares during the period. Renaissance Technologies LLC owned about 1.21% of Retractable Technologies worth $249,000 at the end of the most recent reporting period. 7.58% of the stock is owned by hedge funds and other institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.